Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Academic Impact of Society of Interventional Radiology Foundation Grants: Report from the Society of Interventional Radiology Foundation/National Institutes of Health Task Force.
Pal K, Weiss CR, Gade TPF, Glasgow E, Gill K, Palacios V, Doshi P, Oklu R, Woodrum D, Sheth RA. Pal K, et al. Among authors: doshi p. J Vasc Interv Radiol. 2024 Nov 4:S1051-0443(24)00690-0. doi: 10.1016/j.jvir.2024.10.030. Online ahead of print. J Vasc Interv Radiol. 2024. PMID: 39505236
Do calorie labels change energy purchased in a simulated online food delivery platform? A multi-arm randomised controlled trial.
Luick M, Bianchi F, Bain F, Bandy L, Doshi P, Hilliard D, Leung J, Mottershaw A, Stuijfzand B, Whitwell-Mak J, Jebb SA, Harper H, Pechey R. Luick M, et al. Among authors: doshi p. Int J Behav Nutr Phys Act. 2024 Sep 17;21(1):103. doi: 10.1186/s12966-024-01638-y. Int J Behav Nutr Phys Act. 2024. PMID: 39289766 Free PMC article. Clinical Trial.
Corrigendum to "Mechanistic modeling of twin screw wet granulation for pharmaceutical formulations: Calibration, sensitivity analysis, and model-driven workflow" [Int. J. Pharm. 659 (2024) 124246].
Bala N, Corrigan J, Ahmed B, Meyer J, Schongut M, Doshi P, Iyer K, Lee K, Rowland M, Litster JD, Dawson N, Smith RM. Bala N, et al. Among authors: doshi p. Int J Pharm. 2024 Oct 25;664:124624. doi: 10.1016/j.ijpharm.2024.124624. Epub 2024 Sep 3. Int J Pharm. 2024. PMID: 39227232 No abstract available.
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.
Schenker M, Burotto M, Richardet M, Ciuleanu TE, Gonçalves A, Steeghs N, Schoffski P, Ascierto PA, Maio M, Lugowska I, Lupinacci L, Leary A, Delord JP, Grasselli J, Tan DSP, Friedmann J, Vuky J, Tschaika M, Konduru S, Vemula SV, Slepetis R, Kollia G, Pacius M, Duong Q, Huang N, Doshi P, Baden J, Di Nicola M. Schenker M, et al. Among authors: doshi p. J Immunother Cancer. 2024 Aug 6;12(8):e008872. doi: 10.1136/jitc-2024-008872. J Immunother Cancer. 2024. PMID: 39107131 Free PMC article. Clinical Trial.
407 results